Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Virologie (Montrouge, France)|September 24, 2022
[Basic core promoter and precore mutations of hepatitis B virus]Alexandra Ducancelle, Adeline Pivert, Françoise Lunel-FabianiClinical Chemistry and Laboratory Medicine|September 21, 2019
Practical approach to method verification in plasma and validation in cerebrospinal fluid under accreditation using a flexible scope in molecular virology: setting up the HIV, HBV and HCV Aptima™ Quant Dx assaysCaroline Lefeuvre, Adeline Pivert, Cong T Tran, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 7, 2020
Evaluation of the Aptima™ HBV Quant Dx assay for semi-quantitative HBV viral load from dried blood spotsSteven Roger, Caroline Lefeuvre, Marine Grison, et al.Joint Bone Spine|February 25, 2014
Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivationFrançoise Lunel-Fabiani, Charles Masson, Alexandra DucancelleThe Journal of Infection|May 13, 2015
Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinicsAlexandra Ducancelle, Justine Reiser, Adeline Pivert, et al.The Journal of Infection|May 16, 2020
Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in FranceCaroline Lefeuvre, Adeline Pivert, Hélène Le Guillou-Guillemette, et al.Scientific Reports|June 17, 2022
Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutantsCaroline Lefeuvre, Marine Roux, Simon Blanchard, et al.Journal of Medical Virology|February 25, 2022
Comparison of performance between three SARS-CoV-2 molecular assays (Aptima™, Laboratory Developed Test-Fusion, and R-GENE®) with special attention to turnaround time, a key point in laboratory managementCaroline Lefeuvre, Adeline Pivert, Emilie Przyrowski, et al.Joint Bone Spine|June 2, 2016
Herpes zoster: Risk and prevention during immunomodulating therapyCong Tri Tran, Alexandra Ducancelle, Charles Masson, et al.Scientific Reports|September 11, 2019
A first experience of transduction for differentiated HepaRG cells using lentiviral technologyAdeline Pivert, Caroline Lefeuvre, Cong-Tri Tran, et al.Pageof 8